Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure
Conclusion
Because there is currently no approved treatment stockpiled for radiation-induced thrombocytopenia, second-generation TPO mimetics and other novel platelet-promoting agents should be developed for this indication.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research
More News: Accidents | Bleeding | Cancer & Oncology | Chemotherapy | Pathology | Study | Thrombocytopenia